Study backs ColonSentry effectiveness
GeneNews (TSX: GEN) says that a poster describing a 786-patient study entitled “Blood RNA Biomarker Detects Both Left- and Right-sided Colorectal Neoplasms” has been accepted for presentation at the...
View ArticleGeneNews partner gets New York okay to market ColonSentry
GeneNews (TSX:GEN) announced that Enzo Clinical Labs, a division of Enzo BioChem (NYSE:ENZ), has received approval from New York State’s Department of Health to market ColonSentry, a blood-based test...
View ArticleNY approval of ColonSentry opens door for GeneNews
Last week’s approval by New York State of GeneNews’ (TSX:GEN) ColonSentry molecular diagnostic test to determine a person’s risk of having colorectal cancer opens the door to the entire U.S. market and...
View Article
More Pages to Explore .....